JPH10513480A - １−（２−［２−イソキサゾル−３−イルベンゾフラン−５−イルオキシ］エチルアミノ）−３−フェノキシ−２（ｓ）−オールを製造するための方法及び中間体 - Google Patents

１−（２−［２−イソキサゾル−３−イルベンゾフラン−５−イルオキシ］エチルアミノ）−３−フェノキシ−２（ｓ）−オールを製造するための方法及び中間体

Info

Publication number
JPH10513480A
JPH10513480A JP9506054A JP50605497A JPH10513480A JP H10513480 A JPH10513480 A JP H10513480A JP 9506054 A JP9506054 A JP 9506054A JP 50605497 A JP50605497 A JP 50605497A JP H10513480 A JPH10513480 A JP H10513480A
Authority
JP
Japan
Prior art keywords
formula
compound
compounds
treating
single bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9506054A
Other languages
English (en)
Japanese (ja)
Inventor
デヴリーズ，ケイス・エム
Original Assignee
ファイザー・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファイザー・インコーポレーテッド filed Critical ファイザー・インコーポレーテッド
Publication of JPH10513480A publication Critical patent/JPH10513480A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP9506054A 1995-10-31 1996-08-15 １−（２−［２−イソキサゾル−３−イルベンゾフラン−５−イルオキシ］エチルアミノ）−３−フェノキシ−２（ｓ）−オールを製造するための方法及び中間体 Pending JPH10513480A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US815395P 1995-10-31 1995-10-31
US60/008,153 1995-10-31
PCT/IB1996/000803 WO1997016432A1 (en) 1995-10-31 1996-08-15 Processes and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol

Publications (1)

Publication Number Publication Date
JPH10513480A true JPH10513480A (ja) 1998-12-22

Family

ID=21730067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9506054A Pending JPH10513480A (ja) 1995-10-31 1996-08-15 １−（２−［２−イソキサゾル−３−イルベンゾフラン−５−イルオキシ］エチルアミノ）−３−フェノキシ−２（ｓ）−オールを製造するための方法及び中間体

Country Status (15)

Country Link
EP (1) EP0861240A1 (hu)
JP (1) JPH10513480A (hu)
KR (1) KR19990067172A (hu)
CN (1) CN1201455A (hu)
AU (1) AU6628596A (hu)
BR (1) BR9611217A (hu)
CA (1) CA2234081A1 (hu)
CZ (1) CZ130898A3 (hu)
HR (1) HRP960502A2 (hu)
HU (1) HUP9900090A3 (hu)
IL (1) IL123623A0 (hu)
PL (1) PL327997A1 (hu)
TR (1) TR199800710T2 (hu)
WO (1) WO1997016432A1 (hu)
YU (1) YU57396A (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013224291A (ja) * 2012-04-20 2013-10-31 Rohm & Haas Co ベンジルアミン疎水性物質

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120253481A1 (en) * 2011-03-29 2012-10-04 General Electric Company Hart channel interface component including redundancy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2164009A1 (en) * 1993-06-14 1994-12-22 Robert L. Dow Secondary amines as antidiabetic and antiobesity agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013224291A (ja) * 2012-04-20 2013-10-31 Rohm & Haas Co ベンジルアミン疎水性物質

Also Published As

Publication number Publication date
YU57396A (sh) 1998-11-05
EP0861240A1 (en) 1998-09-02
MX9803497A (es) 1998-09-30
CZ130898A3 (cs) 1999-03-17
IL123623A0 (en) 1998-10-30
HRP960502A2 (en) 1998-04-30
PL327997A1 (en) 1999-01-04
CN1201455A (zh) 1998-12-09
TR199800710T2 (xx) 1998-08-21
HUP9900090A3 (en) 1999-11-29
BR9611217A (pt) 1999-04-06
WO1997016432A1 (en) 1997-05-09
CA2234081A1 (en) 1997-05-09
HUP9900090A2 (hu) 1999-10-28
KR19990067172A (ko) 1999-08-16
AU6628596A (en) 1997-05-22

Similar Documents

Publication Publication Date Title
AU617139B2 (en) New phenylethanolamines
FI72715C (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 2-hydroximetyl-3,4,5-trihydroxipiperidinderivat.
EP0006766B1 (en) Phenethanolamines, their formulations, use and preparation
EP0117647A1 (en) Improvements in or relating to phenethanolamines
DE69722258T2 (de) Neue verbindungen nutlich als neuroschützende mittel
DE2332837A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
CN1324349A (zh) 吡嗪类化合物
US4892886A (en) Phenoxypropanolamines
JPH10513480A (ja) １−（２−［２−イソキサゾル−３−イルベンゾフラン−５−イルオキシ］エチルアミノ）−３−フェノキシ−２（ｓ）−オールを製造するための方法及び中間体
EP0500853A1 (de) Phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung.
MXPA98003497A (en) Procedures and intermediates for preparing 1- (2- [2-isoxazol-3-ilbenzofuran-5-iloxi] ethylamino) -3-fenoxy-2 (s)
EP0345591A1 (de) Propanolaminderivate
US11932610B1 (en) 4-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)butanoic acid as an antimicrobial compound
AT371101B (de) Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon
US11939305B1 (en) Ethyl 2-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetate as an antimicrobial compound
US11958847B1 (en) Pyrazolidinedione derivatives and their use as PPAR-gamma inhibitors
WO2003072573A1 (en) Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
WO2021245281A1 (en) Methods of treatment of tuberous sclerosis complex
DE3809775A1 (de) Neue heterocyclisch substituierte morpholine und morpholin-n-oxide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE1695011A1 (de) Verfahren zur Herstellung von neuen Morpholinderivaten
JPS6365662B2 (hu)
CH655931A5 (en) Oxazolidines
NZ227196A (en) Phenylethanolamine derivatives and their pharmaceutical and veterinary compositions
WO2003072571A1 (en) Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist